Led by Dr. Mao Mao and a multidisciplinary team from leading Chinese hospitals, the multicenter retrospective study enrolled 1,814 participants, including 1,095 lung cancer patients. Blood samples ...
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced a ...
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW),a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced continued sales growth of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results